KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 1 filers reported holding KRONOS BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 4.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,995 | -24.4% | 16,150 | 0.0% | 0.00% | – |
| Q2 2023 | $27,778 | +17.8% | 16,150 | 0.0% | 0.00% | – |
| Q1 2023 | $23,579 | -95.7% | 16,150 | -95.3% | 0.00% | -100.0% |
| Q4 2022 | $553,721 | -59.2% | 341,803 | -15.6% | 0.00% | -66.7% |
| Q3 2022 | $1,357,000 | -7.9% | 404,975 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $1,474,000 | -53.7% | 404,975 | -8.1% | 0.00% | -33.3% |
| Q1 2022 | $3,185,000 | -49.1% | 440,689 | -4.2% | 0.01% | -50.0% |
| Q4 2021 | $6,253,000 | -33.3% | 460,151 | +2.9% | 0.01% | -40.0% |
| Q3 2021 | $9,374,000 | -18.7% | 447,215 | -7.1% | 0.02% | -13.0% |
| Q2 2021 | $11,524,000 | -12.7% | 481,169 | +6.6% | 0.02% | -17.9% |
| Q1 2021 | $13,206,000 | +106.7% | 451,169 | +110.9% | 0.03% | +100.0% |
| Q4 2020 | $6,389,000 | – | 213,891 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $57,961,000 | 16.60% |
| Omega Fund Management, LLC | 3,818,283 | $80,031,000 | 8.98% |
| Wildcat Capital Management, LLC | 1,438,232 | $30,145,000 | 3.90% |
| COMMODORE CAPITAL LP | 298,839 | $6,264,000 | 1.65% |
| Perceptive Advisors | 2,421,142 | $50,747,000 | 0.74% |
| Alphabet Inc. | 1,438,232 | $30,145,000 | 0.72% |
| Artal Group S.A. | 1,317,954 | $27,624,000 | 0.62% |
| Choate Investment Advisors | 393,436 | $8,246,000 | 0.53% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $11,056,000 | 0.51% |
| Coastal Bridge Advisors, LLC | 78,635 | $1,648,000 | 0.38% |